Suvoda Publishes Findings From Survey on Digital Document Review and Consent
A recent survey from Suvoda about attitudes toward digital document review and consent shows that an overwhelming majority of people are comfortable reading and signing documents digitally, however, there is still reluctance when it comes to signing medical consent forms digitally.
The survey from Suvoda found that a majority of respondents (84% in the US and 73% in the UK) indicated they are comfortable signing financial, medical, education and travel documents electronically, yet just half of US respondents and 28% of UK respondents said they prefer to sign medical consent forms electronically. This preference holds up across age groups and locations of residency (urban vs. rural).
Also of note, while one-third of respondents said there is nothing that would prevent them from signing a consent form for a medical procedure or clinical trial, the main roadblocks articulated by the remaining respondents were that the forms are too confusing (46%), too long (25%), and not available in the patient’s native language (19%).
The Suvoda study was a general population Google survey of 723 US participants and 1,000 UK participants. It was conducted in the fall of 2022.
Reference
Survey From Suvoda Shows Comfort With Electronic Signatures is on the Rise, Yet Healthcare Consent Still Lags. (2023, April 19). Suvoda LLC.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
